The O’Neal Comprehensive Cancer Center at UAB is pleased to announce that Rebecca Arend, M.D., MSPH, will join Drs. Narendra Wajapeyee and Suzanne Lapi as Co-Leader of the O’Neal Experimental Therapeutics Research Program.
Over $1 million has been raised for ovarian cancer research through the Drive Out Ovarian Cancer car tag. Written by: Shawna Masters Media contact: Brianna Hoge Over $1 million has been raised for ovarian cancer research.
/PRNewswire/ Leap Therapeutics, Inc. (NASDAQ: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, and BeiGene,.